Logo image
Polycystic kidney disease is significantly associated with dementia risk
Journal article   Peer reviewed

Polycystic kidney disease is significantly associated with dementia risk

Tung-Min Yu, Ya-Wen Chuang, Kuo-Ting Sun, Mei-Ching Yu, Shiang-Cheng Kung, Brian K Lee, Shih-Ting Huang, Cheng-Hsu Chen, Cheng-Li Lin and Chia-Hung Kao
Neurology, v 89(14), pp 1457-1463
03 Oct 2017
PMID: 28855402

Abstract

Age Factors Aged Cohort Studies Comorbidity Dementia - classification Dementia - epidemiology Female Humans Incidence Male Middle Aged Mutation - genetics Polycystic Kidney Diseases - epidemiology Polycystic Kidney Diseases - genetics Proportional Hazards Models Risk Factors TRPP Cation Channels - genetics
Data on the risk of neurodegenerative diseases, including Alzheimer disease (AD) and Parkinson disease (PD), in patients with polycystic kidney disease (PKD) are lacking. A total of 4,229 patients who were aged ≥20 years and had received a diagnosis of PKD were included in the PKD cohort. For each PKD case identified, 1 participant aged ≥20 years without a history of PKD, dementia, or PD was selected from the comparison cohort. For each patient with PKD, the corresponding controls were selected 1:1 on the basis of the nearest propensity score calculated using logistic regression. The incidence density rates of dementia were 4.31 and 2.50 per 1,000 person-years in the PKD and control cohorts, respectively. A 2.04-fold higher risk of dementia was observed in patients with PKD than in controls (adjusted hazard ratio [aHR] 2.04; 95% confidence interval [CI] 1.46-2.85). Regarding the risk of different dementia subtypes, including AD and vascular dementia (VaD), the aHR for AD and presenile dementia was 2.71 (95% CI 1.08-6.75) and that for VaD was 0.90 (95% CI 0.43-1.87) in patients with PKD compared with controls, after adjustment for age, sex, and comorbidities. Compared with controls, the risk of PD increased by 1.78-fold (95% CI 1.14-2.79) in patients with PKD. In clinical practice, health care professionals should be aware of the risk of neurodegenerative diseases in patients with PKD.

Metrics

12 Record Views
9 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
International collaboration
Web of Science research areas
Clinical Neurology
Logo image